It has also been demonstrated that the drug promotes apoptosis by reducing AKT1 activity, enhancing cancer cell sensitivity to TRAIL, increasing ROS levels, and disrupting mitochondrial membrane potential (MMP). Here, TNFSF10 is linked to cancer.